Key messages
- Antimicrobial resistance (AMR) is a global, multi-sectoral issue that affects all countries and, if unaddressed, would widely stress health systems
- To curb the AMR threat, the range of infection challenges and medical needs must be matched with a diversity of informed treatment approaches
- A diverse pipeline of innovative solutions is being developed by SMEs to meet this challenge
- New outcomes, and tools to quantify them, are now awaited to help differentiating existing and upcoming products and measure their performance
To do so, a categorization of the antimicrobial approaches based on the pathogenesis of infectious disease is proposed.
Full Memo available here